| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |